GDTCCytoMed Therapeutics Ltd

Nasdaq w2.cytomed.sg


$ 2.01 $ -0.10 (-4.85 %)    

Monday, 06-May-2024 13:04:32 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 2.05
$ 2.47
$ 0.00 x 0
$ 0.00 x 0
$ 2.01 - $ 2.47
$ 1.92 - $ 9.25
3,444
na
-1
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cytomed-therapeutics-announces-research-collaboration-with-singapore-sengkang-general-hospital-to-advance-injectable-umbilical-cord-derived-mesenchymal-stem-cells-for-cartilage-diseases-and-repair

CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical compan...

 why-container-store-group-shares-are-trading-lower-by-around-23-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Container Store Group, Inc. (NYSE: TCS) shares fell sharply during Wednesday’s session following weak quarterly ...

 us-stocks-gain-uber-posts-upbeat-sales

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market openin...

 cytomed-therapeutics-signs-hoa-and-mou-to-advance-research-on-allogeneic-gamma-delta-t-cell-technology

CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical compan...

 benchmark-reiterates-speculative-buy-on-cytomed-therapeutics-maintains-5-price-target

Benchmark analyst Bruce Jackson reiterates CytoMed Therapeutics (NASDAQ:GDTC) with a Speculative Buy and maintains $5 price ...

 cytomed-therapeutics-reports-1h-2023-financial-report-and-provides-corporate-update-cash-and-cash-equivalents-as-of-june-30-2023-the-company-had-cash-and-cash-equivalents-of-772m

Financial Results for the Six Months Ended June 30, 2023Net Loss: For the six months ended June 30, 2023, the Company's una...

 cytomed-expands-research-collaboration-into-china-after-entering-into-mou-with-china-based-hangzhou-cnk-therapeutics-co-ltd

 CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "the Company"), a Singapore biopharmaceutical company...

 cytomed-therapeutics-announces-china-research-collaboration-to-enhance-its-allogeneic-car--t-in-vivo-persistency-the-mou-signed-by-cytomed-and-hangzhou-cnk-therapeutics-co-ltd-is-the-first-of-several-collaborative-efforts-in-north-asia

The MOU signed by CytoMed and Hangzhou CNK Therapeutics Co., Ltd is the first of several collaborative efforts in North Asia.  ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION